Let us see what happens today.
Pfizer, sold $123 billion dollars worth of Lipitor over 14 years, while their drug was patent protected.
It was the best money spinner they had in their drug stable.
On the face of it, NYR's product should be better, more efficacious and less side affects.
Also if they could get a sole agreement with Pfizer to combine it with Lipitor as a treatment, well, Lord only knows what could happen?
Time will tell, I am willing to wait, at least a couple more years. GLTA
Ann: Nyrada Announces US Patent Grant for PCSK9 Inhibitor, page-16
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.010(8.33%) |
Mkt cap ! $20.04M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.0¢ | 11.0¢ | $72.78K | 624.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 302090 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| NYR (ASX) Chart |